With new and extensively updated information on everything from current treatment guidelines to off-label uses, AHFS Drug Information® 2026 Edition is a necessary addition to your pharmacy's resources. It is the most comprehensive evidence-based source of drug information complete with ongoing updates of therapeutic guideline recommendations, important cautionary information, and other timely and relevant topics related to drug therapy management.
AHFS® DI™ is federally recognized as an official compendium for establishing drug use standards, the only compendium published by a professional and scientific society, and is the drug information reference trusted by pharmacists and other healthcare professionals for over 60 years.
Published under the Editorial Authority of ASHP®
American Society of Health-System Pharmacists®
EDITORIAL STAFF:
Daniel J. Cobaugh, PharmD, DABAT, FAACT Senior Vice President, Professional Development and Publishing.
Michael Gabay, PharmD, JD, BCPS, FCCP AHFS Editor-in-Chief and Senior Editorial Director
Shingyee Cindy Huang, PharmD, Deputy Editor-in-Chief.
The University of Illinois at Chicago Drug Information Group, Principal Editorial Contributors
Editorial Contributors: Nicole Acquisto, PharmD, FASHP, FCCM, FCCP, BCCCP; Linda Bedford Arcuri, PharmD; Heather Draper, PharmD, BCPS, BCEMP; Justyna Fydrych, PharmD; Micheline Goldwire PharmD, MS, MA; Donna Lisi, PharmD; Natalie A. Mendham, PharmD; Cambrey Bao-Phuong Nguyen, PharmD; Kelly Pillinger, PharmD, BCPS, BCIDP; Tonya Scardina, PharmD, BCIDP; Margaret Segovia, PharmD; Elaine K. Snow, BS Pharm; Karen M. Whalen, BS Pharm, BCPS, FASHP; and Barbara F. Young, PharmD, MHA.
Contributors: Auburn University Drug Information Service; Belmont University Drug Information Service; Creighton University Drug Information Service; Medical University of South Carolina Drug Information Service; the University of Arizona Drug Information Service; the University of Missouri, Kansas City Drug Information Service; and the University of Rhode Island Drug Information Service
Editorial Director, Injectable Drug Information: Natalie C. Rosanelli, PharmD
Clinical Informatics Analyst: Kevin Son, PharmD, MHI
Editorial Coordinator: Alexandra Rallo, BA
Content Management and Publishing Specialist: Shawna Rafalko, BA
Director of Production and Platform Services: Johnna Hershey, BA
Consultant: Elizabeth Shannon, BS
FORMER EDITORS
Charles B. Cleveland
Donald E. Francke
William M. Heller
Judith A. Kepler
George P. Provost
Mary Jo Reilly
Gerald K. McEvoy
Elaine K. Snow
AHFS ONCOLOGY EXPERT COMMITTEE
Chase Ayres, PharmD, BCOP
Jason Bergsbaken, PharmD, MBS, BCOP
Rachel Bubik, PharmD, BCOP, BCPS
Caroline Clark, MSN, APRN, OCN, AG-CNS
Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP
Christine Gegeckas, RPh, BCOP
Chelsea Gustafson*, PharmD, BCOP
Kirollos Hanna, PharmD, BCPS, BCOP
Isabel Houlzet*, PharmD, BCPS, BCOP
Andrew (Weiyi) Li, PharmD
Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP
Eve Segal, PharmD, BCOP
Kate Taucher, PharmD, MHS, BCOP, FASHP, FAPO
John Villano, MD, PhD
Kathleen Wiley, MSN, RN, AOCNS* Appointed in cooperation with the Hematology/Oncology Pharmacy Association (HOPA)